Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sotagliflozin as an adjunct to insulin in adults with Type 1 Diabetes; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-10-30